NOS3 and scleroderma: The <i>MMP9</i> risk genotype did not correlate with scleroderma-specific autoantibodies, while the <i>NOS3</i> GG genotype was associated with lower serum levels of anti-collagen IV antibodies (<i>p</i> = 0.039).